Nomura Holdings’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4M Sell
50,658
-43,427
-46% -$10.1M 0.03% 370
2025
Q4
$19.5M Sell
94,085
-3,688
-4% -$729K 0.03% 321
2025
Q3
$18.1M Sell
97,773
-11,238
-10% -$1.93M 0.03% 340
2025
Q2
$16.7M Sell
109,011
-19,063
-15% -$2.93M 0.03% 294
2025
Q1
$21.2M Sell
128,074
-47,311
-27% -$7.4M 0.04% 277
2024
Q4
$25.4M Buy
175,385
+126,058
+256% +$19.5M 0.03% 261
2024
Q3
$7.99M Sell
49,327
-5,982
-11% -$953K 0.02% 506
2024
Q2
$8.08M Buy
55,309
+35,953
+186% +$5.35M 0.02% 521
2024
Q1
$3.06M Sell
19,356
-41,826
-68% -$6.66M 0.01% 777
2023
Q4
$9.59M Buy
61,182
+20,043
+49% +$3.07M 0.03% 465
2023
Q3
$6.41M Buy
41,139
+11,605
+39% +$1.91M 0.02% 456
2023
Q2
$4.89M Buy
29,534
+23,039
+355% +$3.72M 0.01% 499
2023
Q1
$1.01M Buy
6,495
+6,409
+7,452% +$1.03M ﹤0.01% 1021
2022
Q4
$15K Sell
86
-9,796
-99% -$1.69M ﹤0.01% 1330
2022
Q3
$1.63M Buy
9,882
+9,425
+2,062% +$1.59M 0.01% 850
2022
Q2
$81K Sell
457
-59,461
-99% -$10.6M ﹤0.01% 1423
2022
Q1
$10.5M Buy
59,918
+7,600
+15% +$1.29M 0.03% 369
2021
Q4
$8.87M Buy
52,318
+20,551
+65% +$3.36M 0.02% 526
2021
Q3
$5.12M Sell
31,767
-4,230
-12% -$722K 0.01% 613
2021
Q2
$5.91M Buy
35,997
+21,918
+156% +$3.63M 0.02% 524
2021
Q1
$2.3M Sell
14,079
-76,177
-84% -$12.3M 0.01% 808
2020
Q4
$14M Sell
90,256
-319,643
-78% -$47.2M 0.02% 353
2020
Q3
$60.9M Buy
409,899
+133,774
+48% +$19.8M 0.13% 105
2020
Q2
$39.2M Buy
276,125
+274,194
+14,200% +$40M 0.14% 108
2020
Q1
$256K Sell
1,931
-893,891
-100% -$127M ﹤0.01% 731
2019
Q4
$128M Buy
895,822
+735,892
+460% +$99.8M 0.48% 34
2019
Q3
$20.7M Sell
159,930
-90,315
-36% -$11.9M 0.08% 197
2019
Q2
$34.6M Sell
250,245
-21,199
-8% -$2.93M 0.15% 118
2019
Q1
$37.4M Sell
271,444
-54,682
-17% -$7.32M 0.16% 104
2018
Q4
$41.7M Sell
326,126
-134,324
-29% -$18.7M 0.16% 109
2018
Q3
$64.5M Buy
460,450
+259,585
+129% +$34.5M 0.23% 93
2018
Q2
$24.4M Sell
200,865
-293,847
-59% -$36.7M 0.08% 199
2018
Q1
$63.6K Sell
494,712
-192,622
-28% -$26M 0.11% 110
2017
Q4
$95.6M Buy
687,334
+351,291
+105% +$48.9M 0.17% 78
2017
Q3
$43.8M Buy
336,043
+44,578
+15% +$5.91M 0.09% 127
2017
Q2
$38.6M Buy
291,465
+195,696
+204% +$25M 0.09% 128
2017
Q1
$12M Sell
95,769
-165,006
-63% -$19.7M 0.03% 247
2016
Q4
$30.1M Buy
260,775
+164,444
+171% +$19M 0.08% 155
2016
Q3
$11.4M Buy
96,331
+36,288
+60% +$4.4M 0.03% 256
2016
Q2
$7.21M Sell
60,043
-61,544
-51% -$6.99M 0.02% 348
2016
Q1
$13M Buy
121,587
+50,100
+70% +$5.19M 0.04% 181
2015
Q4
$7.33M Buy
71,487
+768
+1% +$77.2K 0.02% 310
2015
Q3
$6.63M Sell
70,719
-179,696
-72% -$17.4M 0.02% 315
2015
Q2
$24.5M Buy
250,415
+155,923
+165% +$15.6M 0.07% 132
2015
Q1
$9.51M Sell
94,492
-217,207
-70% -$22.1M 0.03% 234
2014
Q4
$32.5M Buy
311,699
+242,777
+352% +$25.6M 0.09% 143
2014
Q3
$7.33M Buy
68,922
+38,268
+125% +$3.97M 0.02% 548
2014
Q2
$3.19M Sell
30,654
-478,588
-94% -$48.4M ﹤0.01% 888
2014
Q1
$49.7M Buy
509,242
+225,423
+79% +$20.9M 0.02% 134
2013
Q4
$26.1M Sell
283,819
-233,745
-45% -$21.5M 0.12% 109
2013
Q3
$44.9M Buy
517,564
+268,499
+108% +$24.1M 0.27% 65
2013
Q2
$21.4M Buy
+249,065
New +$21.1M 0.17% 89

Other funds holding JNJ

Nomura Holdings's JNJ Position: Q1 2026 in Review

Nomura Holdings reduced its Johnson & Johnson (JNJ) stake by 46% in Q1 2026, selling an estimated $10.1M and leaving 50,658 shares worth $12.4M. The position accounts for 0.03% of the portfolio, ranked #370.

Nomura Holdings first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $128M in Q4 2019. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Nomura Holdings held 50,658 shares of Johnson & Johnson worth $12.4M as of Q1 2026.
  • Nomura Holdings sold 43,427 Johnson & Johnson shares in Q1 2026, an estimated $10.1M.
  • Johnson & Johnson made up 0.03% of Nomura Holdings's portfolio in Q1 2026, its #370 holding.
  • Nomura Holdings first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Nomura Holdings's Johnson & Johnson position peaked at $128M in Q4 2019.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.